Comparison of Two Different PCR-based Methods for Detection of GAA Expansions in Frataxin Gene

Background: Expansion of GAA trinucleotide repeats is the molecular basis of Friedreich’s ataxia (FRDA). Precise detection of the GAA expansion repeat in frataxin gene has always been a challenge. Different molecular methods have been suggested for detection of GAA expansion, including; short-PCR, l...

Full description

Bibliographic Details
Published in:	Iranian Journal of Public Health
Main Authors:	Mona ENTEZAM, Akbar AMIRFIROOZI, Mansoureh TOGHA, Mohammad KERAMATIPOUR
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2017-02-01
Subjects:	Triplet repeat primed-PCR Long-PCR GAA trinucleotide repeat Friedreich’s ataxia Frataxin (FXN) gene
Online Access:	https://ijph.tums.ac.ir/index.php/ijph/article/view/9052

Similar Items

A new FRDA mouse model [Fxnnull:YG8s(GAA) > 800] with more than 800 GAA repeats
by: Ester Kalef-Ezra, et al.
Published: (2023-01-01)

Detection of interruptions in the GAA trinucleotide repeat expansion in the FXN gene of Friedreich ataxia
by: Timothy P. Holloway, et al.
Published: (2011-03-01)

Friedreich's Ataxia – A Clinical Diagnosis
by: Md. Fekarul Islam, et al.
Published: (2015-01-01)

Difficulties translating antisense-mediated activation of Frataxin expression from cell culture to mice
by: Audrius Kilikevicius, et al.
Published: (2022-12-01)

The Regulation of the Disease-Causing Gene <i>FXN</i>
by: Yi Na Dong, et al.
Published: (2024-06-01)

Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model
by: Chiranjeevi Sandi, et al.
Published: (2011-06-01)

Detection of large expansions in myotonic dystrophy type 1 using triplet primed PCR
by: Susmita eSingh, et al.
Published: (2014-04-01)

Neurobehavioral deficits of mice expressing a low level of G127V mutant frataxin
by: Daniel Fil, et al.
Published: (2023-02-01)

A Drug Combination Rescues Frataxin-Dependent Neural and Cardiac Pathophysiology in FA Models
by: Rosella Abeti, et al.
Published: (2022-05-01)

Revisiting Friedreich's Ataxia: Phenotypic and Imaging Characteristics
by: Rohan Mahale, et al.
Published: (2024-04-01)

Inducible and reversible phenotypes in a novel mouse model of Friedreich’s Ataxia
by: Vijayendran Chandran, et al.
Published: (2017-12-01)

Anti-gene oligonucleotides targeting Friedreich’s ataxia expanded GAA⋅TTC repeats increase Frataxin expression
by: Negin Mozafari, et al.
Published: (2025-06-01)

Frataxin deficiency unveils cell-context dependent actions of insulin-like growth factor I on neurons
by: Franco Carolina, et al.
Published: (2012-10-01)

A peptide derived from TID1S rescues frataxin deficiency and mitochondrial defects in FRDA cellular models
by: Yi Na Dong, et al.
Published: (2024-03-01)

Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration
by: Kuchuan Chen, et al.
Published: (2016-06-01)

Gene expression profiling in frataxin deficient mice: Microarray evidence for significant expression changes without detectable neurodegeneration
by: Giovanni Coppola, et al.
Published: (2006-05-01)

Comparative multi-omic analyses of cardiac mitochondrial stress in three mouse models of frataxin deficiency
by: Nicole M. Sayles, et al.
Published: (2023-10-01)

Friedreichs ataxia in a diabetic patient
by: Inna Igorevna Klefortova, et al.
Published: (2010-06-01)

DNA Base Damage Repair Crosstalks with Chromatin Structures to Contract Expanded GAA Repeats in Friedreich’s Ataxia
by: Yanhao Lai, et al.
Published: (2024-07-01)

Protoporphyrin IX Binds to Iron(II)-Loaded and to Zinc-Loaded Human Frataxin
by: Ganeko Bernardo-Seisdedos, et al.
Published: (2023-01-01)

A Combined Spectroscopic and In Silico Approach to Evaluate the Interaction of Human Frataxin with Mitochondrial Superoxide Dismutase
by: Davide Doni, et al.
Published: (2021-11-01)

The flash-small-pool PCR: how to transform blotting and numerous hybridization steps into a simple denatured PCR
by: Elodie Dandelot, et al.
Published: (2018-06-01)

Novel intragenic deletion within the FXN gene in a patient with typical phenotype of Friedreich ataxia: may be more prevalent than we think?
by: Cinthia Aguilera, et al.
Published: (2023-12-01)

A Single Common Assay for Robust and Rapid Fragile X Mental Retardation Syndrome Screening From Dried Blood Spots
by: Vivienne J. Tan, et al.
Published: (2018-11-01)

Glial cell activation precedes neurodegeneration in the cerebellar cortex of the YG8–800 murine model of Friedreich ataxia
by: Andrés Vicente-Acosta, et al.
Published: (2024-10-01)

Spinocerebellar ataxia 12 patients have better quality of life than spinocerebellar ataxia 1 and 2
by: Surekha Dabla, et al.
Published: (2022-01-01)

An RNA-seq study in Friedreich ataxia patients identified hsa-miR-148a-3p as a putative prognostic biomarker of the disease
by: Chiara Vancheri, et al.
Published: (2024-05-01)

Perspectives on current models of Friedreich’s ataxia
by: Simge Kelekçi, et al.
Published: (2022-08-01)

Interrogating the “unsequenceable” genomic trinucleotide repeat disorders by long-read sequencing
by: Qian Liu, et al.
Published: (2017-07-01)

Machado Joseph disease severity is linked with gut microbiota alterations in transgenic mice
by: Hasinika K.A.H. Gamage, et al.
Published: (2023-04-01)

Clinical and neuroimaging study of spinocerebellar ataxia type 2
by: Yuan-yuan CHEN, et al.
Published: (2013-06-01)

Alpha–lipoic acid supplementation improves pathological alterations in cellular models of Friedreich ataxia
by: Marta Talaverón-Rey, et al.
Published: (2025-08-01)

Skeletal muscle proteome analysis underpins multifaceted mitochondrial dysfunction in Friedreich’s ataxia
by: Elisabetta Indelicato, et al.
Published: (2023-10-01)

Mechanism of action of 2-aminobenzamide HDAC inhibitors in reversing gene silencing in Friedreich’s ataxia
by: Elisabetta eSoragni, et al.
Published: (2015-03-01)

Clinical and molecular studies in five Brazilian cases of Friedreich ataxia Avaliação clínica e molecular de cinco pacientes brasileiros com ataxia de Friedreich
by: IDA V.D. SCHWARTZ, et al.
Published: (1999-03-01)

Oxidative Stress and Antioxidant Therapies in Friedreich’s Ataxia
by: Félix Javier Jiménez-Jiménez, et al.
Published: (2025-09-01)

Therapeutic combination of L-ascorbic acid, N-acetylcysteine, and dimethyl fumarate in Friedreich’s ataxia: insights from in vitro models
by: Fred Jonathan Edzeamey, et al.
Published: (2025-12-01)

Nrf2 Induction Re-establishes a Proper Neuronal Differentiation Program in Friedreich’s Ataxia Neural Stem Cells
by: Piergiorgio La Rosa, et al.
Published: (2019-07-01)

No increase in the CTG repeat size during transmission from parent with expanded allele: false suspicion of contraction phenomenon
by: Goñi Ros Nuria, et al.
Published: (2023-03-01)

Biophysical characterisation of the recombinant human frataxin precursor
by: Ignacio Hugo Castro, et al.
Published: (2018-03-01)